Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management
- PMID: 16289799
- DOI: 10.1016/j.pain.2005.09.010
Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management
Abstract
Anxiety and depression are reported to be frequently associated with migraine but how they impact on migraine-related disability, migraine subjects' quality of life, and medical and therapeutic management of migraine attacks has not been investigated. FRAMIG 3 is a nation-wide population-based postal survey carried out in France according to the 2004 international classification of headache disorders. Subjects who had had migraine attacks during the last 3 months (subjects with 'active migraine', N = 1957) were analysed for migraine-related disability (MIDAS score), quality of life (SF-12 questionnaire), and anxiety and depression (Hospital Anxiety and Depression Scale [HADS]) in comparison with non-migraine subjects (N = 8287). Survey results indicate that 50.6% of subjects with active migraine were anxious and/or depressive (28.0% had anxiety alone, 3.5% depression alone, and 19.1% both anxiety and depression; P < or = 0.01 versus non-migraine subjects for anxiety alone and combined anxiety and depression, NS for depression alone). Although, migraine-associated anxiety and depression do not appear to influence the drugs taken by migraine subjects for the acute treatment of migraine attacks, perceived treatment efficacy and satisfaction with treatment are lower in subjects with anxiety alone or combined with depression than in subjects with neither anxiety nor depression. Anxiety and depression should be systemically looked for and cared for in subjects consulting for migraine.
Similar articles
-
Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.Headache. 2006 May;46(5):715-25. doi: 10.1111/j.1526-4610.2006.00430.x. Headache. 2006. PMID: 16643573
-
The relation of sexual function to migraine-related disability, depression and anxiety in patients with migraine.J Headache Pain. 2014 May 27;15(1):32. doi: 10.1186/1129-2377-15-32. J Headache Pain. 2014. PMID: 24884652 Free PMC article.
-
Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan.Cephalalgia. 2013 Feb;33(3):171-81. doi: 10.1177/0333102412468668. Epub 2012 Nov 30. Cephalalgia. 2013. PMID: 23203506
-
[Anxiety and depression in children and adolescents with migraine: a review of the literature].Encephale. 2008 Oct;34(5):504-10. doi: 10.1016/j.encep.2007.08.005. Epub 2007 Dec 26. Encephale. 2008. PMID: 19068340 Review. French.
-
Migraine diagnosis: screening items, instruments, and scales.Acta Anaesthesiol Taiwan. 2012 Jun;50(2):69-73. doi: 10.1016/j.aat.2012.05.002. Epub 2012 Jun 19. Acta Anaesthesiol Taiwan. 2012. PMID: 22769861 Review.
Cited by
-
The Effect of Oral Chamomile on Anxiety: A Systematic Review of Clinical Trials.Clin Nutr Res. 2024 Apr 23;13(2):139-147. doi: 10.7762/cnr.2024.13.2.139. eCollection 2024 Apr. Clin Nutr Res. 2024. PMID: 38784853 Free PMC article. Review.
-
Unsatisfactory response to acute medications does not affect the medication overuse headache development in pediatric chronic migraine.J Headache Pain. 2024 Apr 23;25(1):61. doi: 10.1186/s10194-024-01766-7. J Headache Pain. 2024. PMID: 38649822 Free PMC article.
-
Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: Review of clinical evidence.Saudi Pharm J. 2024 Apr;32(4):101989. doi: 10.1016/j.jsps.2024.101989. Epub 2024 Feb 15. Saudi Pharm J. 2024. PMID: 38405041 Free PMC article. Review.
-
Migraine Comorbidities.Life (Basel). 2024 Jan 2;14(1):74. doi: 10.3390/life14010074. Life (Basel). 2024. PMID: 38255689 Free PMC article. Review.
-
Evidence for converging pathophysiology in complex regional pain-syndrome and primary headache disorders: results from a case-control study.J Neurol. 2024 Apr;271(4):1850-1860. doi: 10.1007/s00415-023-12119-w. Epub 2023 Dec 9. J Neurol. 2024. PMID: 38070030 Free PMC article.
References
-
- Barczak P, Kane N, Andrews S, Congdon AM, Clay JC, Betts T. Patterns of psychiatric morbidity in a genito-urinary clinic. A validation of the Hospital Anxiety Depression scale (HAD). Br J Psychiatry. 1988;152:698-700.
-
- Breslau N, Davis GC. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res. 1993;27:211-221.
-
- Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991;37:11-23.
-
- Breslau N, Davis GC, Schultz LR, Peterson EL. Migraine and major depression: a longitudinal study. Headache. 1994;34:387-393.
-
- Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KMA. Headache and major depression. Is the association specific to migraine? Neurology. 2000;54:308-313.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous